<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: CG Therapeutics, Immune-Booster For Cancer, Recruits Dendreon Vets, New CEO</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/03/10/cg-therapeutics-maker-of-immune-booster-for-cancer-recruits-dendreon-vets-new-ceo/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/03/10/cg-therapeutics-maker-of-immune-booster-for-cancer-recruits-dendreon-vets-new-ceo/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Ron Falcone</title>
		<link>http://www.xconomy.com/seattle/2009/03/10/cg-therapeutics-maker-of-immune-booster-for-cancer-recruits-dendreon-vets-new-ceo/comment-page-1/#comment-121878</link>
		<dc:creator>Ron Falcone</dc:creator>
		<pubDate>Sat, 17 Apr 2010 19:07:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=15519#comment-121878</guid>
		<description>the relationship between hCG and cancer has been well known for over twenty years; AVIbiopharma was the first to launch an anti-hCG trial and showed statistically significant results but that effort was scrapped while Eli&#039;s drug Gemzar---incidentally, one of the co-drugs tested with AVI&#039;s hcg formulation and which didn&#039;t show more superior levels of efficacy--- remains the &#039;approved&#039; drug but with a higher toxicity profile and far greater expense profile. Does economics have anything to do with it?</description>
		<content:encoded><![CDATA[<p>the relationship between hCG and cancer has been well known for over twenty years; AVIbiopharma was the first to launch an anti-hCG trial and showed statistically significant results but that effort was scrapped while Eli’s drug Gemzar—incidentally, one of the co-drugs tested with AVI’s hcg formulation and which didn’t show more superior levels of efficacy— remains the ‘approved’ drug but with a higher toxicity profile and far greater expense profile. Does economics have anything to do with it?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Richard Lentini</title>
		<link>http://www.xconomy.com/seattle/2009/03/10/cg-therapeutics-maker-of-immune-booster-for-cancer-recruits-dendreon-vets-new-ceo/comment-page-1/#comment-109653</link>
		<dc:creator>Richard Lentini</dc:creator>
		<pubDate>Thu, 11 Feb 2010 23:33:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=15519#comment-109653</guid>
		<description>In the mid-1970s I had a MS degree in medical physiology and was working on a Ph.D. in experimental pathology at the University of Florida medical school. I noticed medical literature showed that the most aggressive cancers (the most dedifferentiated and metastatic cancers) produced hCG (or perhaps hCG subunits).  I was intrigued by this and wanted to study this phenomenon because hCG also seemed to protect the fetus by way of the trophoblast.   Unfortunately, my major professor was not intrigued about this phenomenon and I was not able to complete my Ph.D. degree. I completed everything but a dissertation which would have been a study involving the immunosuppression effects of hCG in cancer.   

I now have small cell lung cancer yet cannot, under any circumstances, get anti-hCG to see if it would prolong my life. This is so frustrating because I was sure hCG was so important in cancer research.  

Richard S. Lentini
ricklend@yahoo.com</description>
		<content:encoded><![CDATA[<p>In the mid-1970s I had a MS degree in medical physiology and was working on a Ph.D. in experimental pathology at the University of Florida medical school. I noticed medical literature showed that the most aggressive cancers (the most dedifferentiated and metastatic cancers) produced hCG (or perhaps hCG subunits).  I was intrigued by this and wanted to study this phenomenon because hCG also seemed to protect the fetus by way of the trophoblast.   Unfortunately, my major professor was not intrigued about this phenomenon and I was not able to complete my Ph.D. degree. I completed everything but a dissertation which would have been a study involving the immunosuppression effects of hCG in cancer.   </p>
<p>I now have small cell lung cancer yet cannot, under any circumstances, get anti-hCG to see if it would prolong my life. This is so frustrating because I was sure hCG was so important in cancer research.  </p>
<p>Richard S. Lentini<br />
<a href="mailto:ricklend@yahoo.com">ricklend@yahoo.com</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lorraine Morgan</title>
		<link>http://www.xconomy.com/seattle/2009/03/10/cg-therapeutics-maker-of-immune-booster-for-cancer-recruits-dendreon-vets-new-ceo/comment-page-1/#comment-50133</link>
		<dc:creator>Lorraine Morgan</dc:creator>
		<pubDate>Thu, 12 Mar 2009 08:56:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=15519#comment-50133</guid>
		<description>I think this is wonderful news!  Just a shame that Big Venture capitalists are frightened to invest!  What can be done?  As a Breast Cancer victim myself and other members of my family have had various types of Cancer...it gives me hope!</description>
		<content:encoded><![CDATA[<p>I think this is wonderful news!  Just a shame that Big Venture capitalists are frightened to invest!  What can be done?  As a Breast Cancer victim myself and other members of my family have had various types of Cancer…it gives me hope!</p>
]]></content:encoded>
	</item>
</channel>
</rss>

